DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of California Cryobank LLC Customers Whose Data May Have Been Compromised
NEWTOWN, Pa., March 19, 2025 (GLOBE NEWSWIRE) -- Edelson Lechtzin LLP, a national class action law firm, is investigating data privacy violations at California Cryobank LLC ('CCB'). CCB learned of unauthorized activity on its computer network between April 20, 2024, and April 22, 2024. To join this case, go HERE.
About California Cryobank LLC
California Cryobank, a unit of CooperSurgical, specializes in reproductive tissue preservation, including donor sperm and egg services, long-term storage, and cord blood banking.
What happened?
Between April 20, 2024, and April 22, 2024, CCB experienced a cyber security incident involving unauthorized activity on its IT network. The company launched an investigation and discovered that certain files containing sensitive personal information may have been stolen or accessed.
What type of information was stolen?
The personal information in the compromised files may have included:
Names
Driver's License Numbers
Bank Account/Routing Numbers
Payment Card Numbers
How can I protect my personal data?
If you receive a data breach notification concerning CCB, you must guard against possible misuse of your personal information, including identity theft and fraud, by regularly reviewing your account statements and monitoring your credit reports for suspicious or unauthorized activity.
Edelson Lechtzin LLP is investigating a class action lawsuit to seek legal remedies for individuals whose sensitive personal data may have been compromised by the CCB data breach.
For more information, please contact:
Marc H. Edelson, Esq.
EDELSON LECHTZIN LLP
411 S. State Street, Suite N-300
Newtown, PA 18940
Phone: 844-696-7492 ext. 2
Email: [email protected]
Web: www.edelson-law.com
About Edelson Lechtzin LLP
Edelson Lechtzin LLP is a national class action law firm with offices in Pennsylvania and California. In addition to cases involving data breaches, our lawyers focus on class and collective litigation in cases alleging securities and investment fraud, violations of the federal antitrust laws, employee benefit plans under ERISA, wage theft and unpaid overtime, consumer fraud, and catastrophic injuries.
This press release may be considered Attorney Advertising in some jurisdictions.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 days ago
- Yahoo
Cable One, Inc. (CABO) Faces Legal Scrutiny from Edelson Lechtzin LLP
Citing possible breaches of federal securities regulations, Edelson Lechtzin LLP has launched an investigation into Cable One, Inc. (NYSE:CABO). The inquiry follows serious concerns regarding potential misrepresentation of the company's operational outlook ahead of its first-quarter earnings announcement, which sharply missed analyst expectations and resulted in a market backlash. A customer in their home enjoying premium channels, high-definition set-top boxes, and whole-home DVRs. On May 1, 2025, Cable One, Inc. (NYSE:CABO) disclosed disappointing Q1 figures and said it would suspend its previously anticipated dividend. These results and announcements, deviating from the earlier guidance, prompted skepticism from analysts at KeyBanc and Raymond James, who criticized the company's previous forecasts on subscriber and broadband revenue growth. The stock quickly plummeted by 41.79%, reaching $152.51 per share on May 2. Having launched an inquiry on Cable One, Inc. (NYSE:CABO), Edelson Lechtzin LLP calls for those with non-public information related to the company to come forward and assist in the investigation. The probe has been initiated amid CEO Julia M. Laulis's retirement. Laulis has held on to the role for more than two decades at Cable One, Inc. (NYSE:CABO) and has over 40 years of expertise in the cable sector. Founded in Arizona, Cable One, Inc. (NYSE:CABO) delivers broadband internet, voice, and video services across underserved regions in the U.S. The company's core operations are centered around subscriber growth and infrastructure upgrades, areas that are now under investor scrutiny. While we acknowledge the potential of CABO as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 10 Unstoppable Dividend Stocks to Buy Now and 11 Oversold Global Stocks to Buy According to Hedge Funds Disclosure: None. Sign in to access your portfolio
Yahoo
2 days ago
- Yahoo
Semler Scientific, Inc. (SMLR) Faces Scrutiny from Edelson Lechtzin LLP
On June 4, 2025, Edelson Lechtzin LLP announced that it has initiated an inquiry into whether the healthcare technology company, Semler Scientific, Inc. (NASDAQ:SMLR), misled investors about its business operations regarding claims tied to its QuantaFlo diagnostic device. A doctor in focus surrounded by colleagues in a hospital setting. In an annual report filed by Semler Scientific, Inc. (NASDAQ:SMLR) on February 28, 2025, the company disclosed that the U.S. Department of Justice (DOJ) was evaluating a potential False Claims Act case. The report triggered immediate market reaction, with the company's shares plummeting by 9.4% to close at $38.89 on March 3. Initiating the inquiry, Edelson Lechtzin LLP has asked for the public and stakeholders' help. Edelson urges those with non-public information regarding Semler Scientific, Inc. (NASDAQ:SMLR) to come forward and assist them in the investigation. It also encourages the company's investors who have suffered losses to follow the inquiry to learn more. The investor confidence has been significantly fluctuating since the disclosure. The stock's performance, which gained 6.49% last month, declined by 13.46% last week. The California-based company, Semler Scientific, Inc. (NASDAQ:SMLR), is known for developing non-invasive medical tools, with QuantaFlo being its most prominent product. Focusing on early disease detection and chronic condition management, the company has positioned itself between healthcare and technology. While we acknowledge the potential of SMLR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 10 Unstoppable Dividend Stocks to Buy Now and 11 Oversold Global Stocks to Buy According to Hedge Funds Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
2 days ago
- Business Wire
Daniel Aronowitz: I Will End the War on ESOPs
WASHINGTON--(BUSINESS WIRE)--During his confirmation hearing today, Daniel Aronowitz, President Trump's nominee to lead the Employee Benefits Security Administration (EBSA) as Assistant Secretary of Labor, signaled a sea change in how the Department of Labor (DOL) views ESOPs under this Administration. EBSA is the chief regulator of ESOPs at the DOL under the Employment Retirement Income Security Act (ERISA). "I will end the war on ESOPs. I think it's the best way for employees to get an additional benefit and ownership in an American company." Daniel Aronowitz During the hearing at the Senate Health, Education, Labor & Pensions (HELP) Committee, Aronowitz had the following exchange with Senator Lisa Murkowski (AK): SENATOR MURKOWSKI: 'You're probably very familiar with the angst expressed by some about the need for a single clear regulatory definition of good faith effort for valuing ESOP stock. The concern is that, instead of having a clear definition that is spelled out in regulation, ESOPs have been operating under a patchwork of litigation and investigation. There is also some concern that the department has taken excessive enforcement actions against ESOPs. Can you speak briefly to your views on these?" DANIEL ARONOWITZ:"I believe that Congress wants ESOPs and everybody is for ESOPs except for the DOL for the last 20 years. I will end the war on ESOPs. I think it's the best way for employees to get an additional benefit and ownership in an American company. The valuation companies have all been sued by the can't be right that every single one of them is doing it wrong. What the Department is doing is nitpicking the professional judgment of the valuation professionals. I'm going to put an end to that. Because I think unless there is a clear conflict of interest, then the valuation is appropriate when done by an independent valuation firm." In addition, Senator John Husted (OH) added his support for ESOPs during the hearing, saying 'Mr. mentioned something in your testimony about ESOPs, that's a great way to help businesses involve their employees and keep the legacy of those businesses in those communities. So I encourage you to do everything you can to support ESOPs in your role." The ESOP Association, the leading organization representing businesses with an Employee Stock Ownership Plan (ESOP) and the 14 million Americans with an interest in an ESOP, strongly supports the confirmation of Daniel Aronowitz. 'Daniel Aronowitz is uniquely qualified to address the challenges faced by ESOPs, workers, and potential ESOP founders under the current regulatory structure,' said James Bonham, President and CEO of The ESOP Association. 'Today's hearing was the clearest sign yet that the Trump Administration is serious about ending the decades of mistreatment of ESOPs and pursuing a regulatory agenda that will allow ESOPs to flourish. Mr. Aronowitz has overwhelming support among The ESOP Association's members, and should be quickly confirmed.' Before answering questions, in his opening statement submitted to the Committee Aronowitz was clear about his intent toward ESOPs: 'First, I will improve EBSA's enforcement of fiduciary law. We will end the practice of open-ended investigations that go on for years. We will end the bias against ESOPs and other legitimate ways to expand retirement benefits and ownership to America's workers. And we will end the regulatory abuse of common-interest agreements with plaintiff lawyers. EBSA's enforcement will be fair, even-handed, and efficient.' Aronowitz said his experience 'has given me unique insights into how to better protect and expand the retirement and health security of American workers,' and if confirmed he will 'work hard every day to unleash and unlock the creativity and full potential of America's employee benefit system.' 'Daniel Aronowitz should be quickly confirmed so he and Secretary Chavez DeRemer can begin the process of driving the necessary changes at EBSA and fulfill the true promise of ESOPs for American workers and our economy,' Bonham added. 'We thank Chairman Cassidy for his leadership in this process, and hope for a speedy vote in Committee so the full Senate can proceed to Mr. Aronowitz's confirmation.' About The ESOP Association The ESOP Association is the largest organization in the world supporting employee-owned companies, the more than 10 million U.S. employees who participate in an ESOP, and the professionals who provide services to them. Headquartered at the International Employee Ownership Center in Washington, DC and operating as a 501(c)6 organization with the affiliated Employee Ownership Foundation, The ESOP Association conducts and funds academic research, provides more than 160 annual conferences and events attended by nearly 15,000 individuals, and advocates on behalf of employee owners and their businesses to federal and state lawmakers.
